Depixus
- Website
- depixus.com
- Total Funding
- $35.4M
- Last Round
- $35.4M Series ADec 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Depixus is headquartered in France, with its main offices and labs located in the Paris area, at 39 Rue Louis Blanc in Courbevoie. Based on Magnetic Force Spectroscopy (MFS), the company's MAGNA One platform delivers direct, dynamic data on thousands of individual biomolecular interactions, giving researchers a new way to study molecular-level biology at scale.
Summary
Depixus is a Biotech company. It has raised $35.4M in total across 1 round, most recently a $35.4M Series A round in Dec 2021. Investors include Lansdowne Partners, Bpifrance and European Innovation Council Fund.
Funding History
Dec 2021
Investors
Similar Companies
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Global contract research organization providing comprehensive drug development and laboratory ser...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/depixus"><img src="https://indexed.vc/api/badge/company/depixus" alt="Depixus on Indexed.vc" width="260" height="76" /></a>